Rifampin Resistance in Staphylococci after Rifaximin Intake for Surgical Prophylaxis in Elective Colorectal Surgery
- 1 December 2018
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 62 (12)
Abstract
The aim of our study was to determine whether rifampin resistance emerges in human skin staphylococci after oral intake of rifaximin for surgical prophylaxis. Rifampin-resistant staphylococci appeared on the skin of 32 out of 74 patients (43.2%) two weeks after prophylactic treatment with rifaximin.Keywords
This publication has 11 references indexed in Scilit:
- Emergence of rifampin-resistant staphylococci after rifaximin administration in cirrhotic patientsPLOS ONE, 2017
- Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic SensitivityDigestive Diseases and Sciences, 2017
- Rifampin-Resistant Staphylococcus aureus Bacteremia in a Patient on Chronic RifaximinAnnals of Pharmacotherapy, 2017
- Antimicrobial Susceptibility of Staphylococcus Isolates from the Skin of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Treated with Repeat Courses of RifaximinAntimicrobial Agents and Chemotherapy, 2017
- Use of rifaximin in gastrointestinal and liver diseasesWorld Journal of Gastroenterology, 2016
- Bacteraemia with rifampin-resistant Staphylococcus aureus and the potential role of cross-resistance between rifampin and rifaximinJournal of Infection, 2014
- Rifaximin intake leads to emergence of rifampin-resistant staphylococciJournal of Infection, 2011
- Resistance to rifampicin: at the crossroads between ecological, genomic and medical concernsInternational Journal of Antimicrobial Agents, 2010
- Rifaximin: A Novel Nonabsorbed Rifamycin for Gastrointestinal DisordersClinical Infectious Diseases, 2006
- RifaximinDrugs, 1995